Skip to content

Cash ratio at other companies

HRO
HarrowHROW
+0.7×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
+0.6×
XER
Xeris Biopharma Holdings, Inc.XERS
0.9×+0.3×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
1.3×+0.6×
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
1.6×-0.1×

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s cash ratio?
Eton Pharmaceuticals, Inc. (ETON) reported cash ratio of 0.4× in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s cash ratio changed year-over-year?
Eton Pharmaceuticals, Inc.'s cash ratio decreased by 35.2% year-over-year, from 0.7× to 0.4×.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s cash ratio has grown at a -34.6% compound annual growth rate (CAGR), from 5.6× to 0.7×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.